Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Immunotherapy Biomarkers, Treg Targeting

Karen Bhatt

MD

🏢Yale School of Medicine🌐USA

Associate Professor

32
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Karen Bhatt at Yale has contributed to understanding predictive biomarkers for immunotherapy response, with particular focus on the intratumoral immune contexture and the role of regulatory T cells. Her research on how anti-CTLA-4 therapy mediates its effects through Treg depletion in the tumor microenvironment, and on immune biomarkers in tumor biopsies, has informed mechanistic understanding of checkpoint inhibitor activity.

Share:

🧪Research Fields 研究领域

tumor Treg depletion
anti-CTLA-4 mechanism
immunotherapy response biomarkers
tumor CD8/Treg ratio
intratumoral immune correlates

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Karen Bhatt 的研究动态

Follow Karen Bhatt's research updates

留下邮箱,当我们发布与 Karen Bhatt(Yale School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment